Recombinant Protein Market is Projected To Reach A Revised Size of USD 2,320.21 Million By 2029, Growing At A CAGR of 13.02% | Valuates Reports
BANGALORE, India, May 17, 2023 /PRNewswire/ -- Recombinant Protein Market is segmented by Type - Hormones, Growth Factors, Cytokines, Plasma Protein Factor, Recombinant Metabolic Enzymes, Immune Checkpoint Regulators, Others, by Application - Biopharmaceutical Companies, Academic and Research Institutes, Contract Research Organizations. Global Opportunity Analysis and Industry Forecast 2023-2029. It is published in Valuates Reports under the Pharmaceuticals & Biotech Category.
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Recombinant Protein estimated at USD 975.77 million in the year 2022, is projected to reach a revised size of USD 2,320.21 million by 2029, growing at a CAGR of 13.02% during the forecast period 2023-2029.
Major Factors Driving The Growth of The Recombinant Protein Market are
The recombinant protein market will expand over the projected period due to factors like the rise in the prevalence of chronic illnesses, an increase in consumer preference for biosimilars and biologics, and advancements in recombinant products.
Additionally, a larger sum is being spent on the research and development of the items that fall under the category of recombinant proteins, which is projected to spur recombinant protein market expansion in the years to come.
Browse The Table of Contents And List of Figures At https://reports.valuates.com/reports/QYRE-Auto-11J3238/global-recombinant-protein
TRENDS INFLUENCING THE GROWTH OF RECOMBINANT PROTEIN MARKET
Recombinant proteins are used to treat a number of chronic disorders, including dwarfism, congestive heart failure, diabetes, cerebral apoplexy, myocardial infarction, multiple sclerosis, anemia, neutropenia, etc. They are also used in research. In addition, subsequent generations of recombinant proteins made some advancements over the prior generation. The second generation of recombinant proteins included proteins with improved qualities including selectivity, biodistribution, and effectiveness, similar to the previous generation, which included native protein structures. The third generation of recombinant proteins also included novel formulations and delivery methods with improved effectiveness and security. This factor is expected to drive the recombinant protein market.
The global healthcare industry is expanding rapidly, which encourages spending on research and development to find new treatments for a range of illnesses. Recombinant protein production is intimately correlated with the expansion of the healthcare industry and spending on biologics. Additionally, government support stimulated the research efforts of academic institutions and biotechnological companies, resulting in developments in the market for recombinant proteins. This factor is expected to drive the recombinant protein market.
As a result, due to increased research and development costs, an aging population, an increase in the frequency of chronic illnesses, a growing preference for biologics and biosimilars, and the introduction of sophisticated recombinant goods Over the projected period, the recombinant protein market is anticipated to see rapid expansion.
Get Your Sample Today: https://reports.valuates.com/request/sample/QYRE-Auto-11J3238/Global_Recombinant_Protein_Market
RECOMBINANT PROTEIN MARKET SHARE ANALYSIS
Recombinant protein sales in North America were valued at USD 334.79 million in 2022 and are projected to increase to USD 736.53 million by 2029, at a CAGR of 11.75% from 2023 to 2029.
The recombinant protein market in Asia-Pacific was valued at USD 362.89 million in 2022 and will increase to USD 1,010.82 million by 2029, growing at a CAGR of 15.52% from 2023 to 2029.
The recombinant protein market in Europe was valued at USD 240.37 million in 2022 and would increase to USD 508.09 million by 2029, growing at a CAGR of 11.15% from 2023 to 2029.
The market share leader is the sub-segment for recombinant growth factors. Due to their numerous uses, recombinant growth factors have become more prominent in the market. Numerous recombinant growth factors have been demonstrated to hasten the healing of chronic wounds in diabetes individuals. Besides this, clinical nephrology is another area where recombinant growth factors are widely used.
Inquire For Customization:
Market By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Inquire For Regional Report: https://reports.valuates.com/request/regional/QYRE-Auto-11J3238/Global_Recombinant_Protein_Market
Key players
- Thermo Fisher Scientific
- Bio Techne Corporation
- Abcam
- Merck KGaA
- Miltenyi Biotec
- ACROBiosystems
- Sino Biological
- Cytiva
- Eurogentec S.A
- Genscript Biotech Corporation
- Reprocell
- BPS Bioscience
- Abnova Corporation
- Prospec-Tany Technogene
- Ajinomoto
Inquire For Chapter Cost : https://reports.valuates.com/request/chaptercost/QYRE-Auto-11J3238/Global_Recombinant_Protein_Market
Buy Now for Single User + Covid-19 Impact : https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-11J3238&lic=single-user
SUBSCRIPTION
We have introduced a tailor-made subscription for our customers. Please leave a note in the Comment Section to know about our subscription plans.
SIMILAR REPORTS
- Recombinant Protein Therapeutics Market
- Recombinant Protein Drugs Market
- Recombinant Protein Expression Service Market
- Recombinant Trypsin Solution Market
- Recombinant DNA Technology Market
- Recombinant Human Serum Albumin Market Size
- Recombinant Plasma Protein Therapeutics Market was valued at USD 7857.8 million in 2022 and is anticipated to reach USD 11310 million by 2029, witnessing a CAGR of 4.9% during the forecast period 2023-2029.
- Recombinant Human Follicle stimulating Hormone Market
- Synthetic Biology market size is estimated to be worth USD 10060 million in 2022 and is forecast to be a readjusted size of USD 33120 million by 2028 with a CAGR of 22.0% during the review period.
- Genome Editing & Genome Engineering Market is projected to reach a revised size of USD 6739.8 million by 2028, growing at a CAGR of 9.3% during the forecast period 2022-2028.
- Microfluidics Market is projected to reach USD 7397 million by 2028 from an estimated USD 3496.8 million in 2022, at a CAGR of 13.3% during 2023 and 2028.
- Gene Synthesis Market size is projected to reach USD 759 million by 2027, from USD 309.5 million in 2020, at a CAGR of 13.6% during 2021-2027.
- Site Directed Mutagenesis System Market
- Genome Editing Market is projected to reach USD 6739.8 Million by 2028, from USD 3513 Million in 2021, at a CAGR of 9.3% during 2022-2028.
- Cell Analysis Market is projected to reach USD 25610 Million by 2027, from USD 19740 Million in 2020, at a Compound Annual Growth Rate (CAGR) of 3.7% during 2021-2027.
- Cell Culture Market accounted for USD 16,107.7 million in 2019 and is expected to reach USD 36,926.8 million by 2027, registering a CAGR of 10.9% from 2020 to 2027.
- DNA Sequencing Market size was USD 13380 million and it is expected to reach USD 48700 million by the end of 2027, with a CAGR of 20.4% during 2021-2027
- Bioreactors Market is estimated to be worth USD 1523.1 million in 2022 and is forecast to a readjusted size of USD 2154.4 million by 2028 with a CAGR of 6.0% during the review period.
- Single use Bioprocessing Market is projected to reach USD 6956.3 million by 2027, from USD 3905.3 million in 2020, at a CAGR of 10.1% during 2021-2027.
- Digital PCR Market generated USD 508.8 million in 2020 and is projected to reach USD 1,139.9 million by 2028, growing at a CAGR of 9.1% from 2021 to 2028.
- Orphan Drugs Market is projected to reach USD 241610 million by 2027, from USD 122720 million in 2020, at a CAGR of 9.7% during 2021-2027.
- Medical Tubing Market is estimated to be worth USD 8136.6 million in 2022 and is forecast to be a readjusted size of USD 13570 million by 2028 with a CAGR of 8.9% during the review period.
- Global Clinical Flow Cytometry Market Research Report 2022
- Flow Cytometry Market estimated at USD 5.1 billion in the year 2022, is projected to reach a revised size of USD 8.4 billion by 2028, growing at a CAGR of 8.7% during the forecast period 2022-2028.
- Antimicrobial susceptibility testing market was valued at USD 3040.00 million in 2020 and is projected to reach USD 4736.03 million by 2030 registering a CAGR of 5.8% from 2021 to 2030.
- Neurostimulation Devices market is estimated to be worth USD 7454.1 million in 2022 and is forecast to a readjusted size of USD 14170 million by 2028 with a CAGR of 11.3% during the review period.
- Digital PCR (DPCR) and QPCR market is estimated to be worth USD 1419.2 million in 2022 and is forecast to a readjusted size of USD 2165.8 million by 2028 with a CAGR of 7.3% during the review period.
- Sterilization Equipment market was valued at USD 1674.3 million in 2022 and is expected to reach USD 2005.8 million by the end of 2028, growing at a CAGR of 3.06% from 2022 to 2028.v
- Biometrics market is projected to reach USD 39030 million by 2028, from USD 15900 million in 2021, at a CAGR of 13.2% during 2022-2028.
- Fiducial Markers market is estimated to be worth USD 104.8 million in 2022 and is forecast to be a readjusted size of USD 131.4 million by 2028 with a CAGR of 3.9% during the review period
- Dialysis Market was valued at USD 91,205.0 million in 2020 and is estimated to reach USD 129,756.8 million by 2028, registering a CAGR of 4.7% from 2021 to 2028.
- The global Urology Devices market was valued at USD 29300 million in 2022 and is anticipated to reach USD 39810 million by 2029, witnessing a CAGR of 4.0% during the forecast period 2023-2029.
Similar Reports for Recombinant protein Market
About Us:
Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.
Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.
To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains a detailed research methodology employed to generate the report. Please also reach our sales team to get the complete list of our data sources.
Contact Us:
Valuates Reports
sales@valuates.com
For U.S. Toll-Free Call 1-(315)-215-3225
For IST Call +91-8040957137
WhatsApp: +91-9945648335
Website: https://reports.valuates.com
Twitter - https://twitter.com/valuatesreports
Sitemap: https://reports.valuates.com/sitemap/html/reports
https://reports.valuates.com/sitemap/html/reports/600
https://reports.valuates.com/sitemap/html/reports/608
https://reports.valuates.com/sitemap/html/reports/609
Logo: https://mma.prnewswire.com/media/1082232/Valuates_Reports_Logo.jpg
Share this article